US FDA Eyes New Investigational Drug Label Requirements That Bring International Harmonization

Questionable bill bottles. photo illustration/Alamy images
Clinical trial sites are concerned the labels on investigational drugs are confusing • Source: photo illustration/Alamy images
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Clinical Trials

More from R&D